DMAC DiaMedica Therapeutics Inc.
Healthcare$5.91+2.43%ClosedMarket Cap: $318.5M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
6.73
P/S
0.00
EV/EBITDA
-8.55
DCF Value
$0.30
FCF Yield
-9.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-77.1%
ROA
-66.1%
ROIC
-77.4%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | NaN% | $-10.5M | $-10.0M | $— | — |
| Q4 null | $0.00 | NaN% | $-9.2M | $-8.7M | $— | — |
| FY null | $0.00 | NaN% | $-34.4M | $-32.8M | $— | — |
| Q3 null | $0.00 | NaN% | $-9.0M | $-8.6M | $— | — |
| Q2 null | $0.00 | NaN% | $-8.0M | $-7.7M | $— | — |
| Q1 null | $0.00 | NaN% | $-8.1M | $-7.7M | $— | — |
| Q4 null | $0.00 | NaN% | $-8.4M | $-7.9M | $— | — |
| FY null | $0.00 | NaN% | $-26.7M | $-24.4M | $— | — |
| Q3 null | $0.00 | NaN% | $-6.9M | $-6.3M | $— | — |
| Q2 null | $0.00 | NaN% | $-5.6M | $-5.1M | $— | — |
| Q1 null | $0.00 | NaN% | $-5.7M | $-5.2M | $— | — |
| Q4 2023 | $0.00 | -Infinity% | $-5.8M | $-5.2M | $-0.14 | — |